Skip to content
KStart free
AI InfrastructureDefenseQuantumAll studies →

SLN US Equity

Silence Therapeutics plcHealth Care · Pharmaceutical Preparations · CIK 1479615
$13.61
-0.49 (-3.48%)
USD · as of 2026-08-19 · marketstack
4 8-K filings · 2 13D · 1 13G
DateEventWhat happened / filerSource
2026-08-1413D/ASchedule 13D amendment — ≥5% beneficial owner (active intent) · by Griffiths Richard Iansec.gov ↗
2026-08-1313G/ASchedule 13G amendment — ≥5% beneficial owner (passive) · by Invus Global Management, LLCsec.gov ↗
2026-08-128-K 8.01Other eventssec.gov ↗
2026-08-128-K 1.01Entry into a material definitive agreementsec.gov ↗
2026-08-108-K 8.01Other eventssec.gov ↗
2026-08-108-K 7.01Regulation FD disclosuresec.gov ↗
2026-08-108-K 2.02Results of operations and financial condition (earnings)earnings history (EARN) →sec.gov ↗
2026-07-168-K 5.02Departure/election of directors or officers; compensation (amendment)sec.gov ↗
2026-07-0813D/ASchedule 13D amendment — ≥5% beneficial owner (active intent) · by Griffiths Richard Iansec.gov ↗
Source: SEC EDGAR (public domain) · history starts 2026-07-08

Every row is a filed document, checked against its EDGAR index.